<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(10)</volume><submitter>Li CR</submitter><funding>National Key R&amp;D Program of China</funding><funding>Major Projects in Provincial and National Union Construction of Henan Medical Science Research Plan</funding><funding>National Natural Science Foundation of China</funding><funding>National Key Research &amp; Development Project</funding><funding>National Key Research and Development Program of China</funding><funding>Jiangsu Provincial Key Department of Maternal and Child Health Fund</funding><journal>Clinical and translational medicine</journal><pagination>e70051</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11480968</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>BIN2 inhibition suppress ovarian cancer progression meanwhile protect ovarian function through downregulating HDAC1 and RPS6 phosphorylation respectively.</pubmed_title><pmcid>PMC11480968</pmcid><funding_grant_id>FXK201712</funding_grant_id><funding_grant_id>SBGJ202001002</funding_grant_id><funding_grant_id>32070840</funding_grant_id><funding_grant_id>2021YFA1100300</funding_grant_id><funding_grant_id>2021YFC2700602</funding_grant_id><pubmed_authors>Li YR</pubmed_authors><pubmed_authors>Zhang D</pubmed_authors><pubmed_authors>Zhang SP</pubmed_authors><pubmed_authors>Guan YC</pubmed_authors><pubmed_authors>Zhang CL</pubmed_authors><pubmed_authors>Tian PZ</pubmed_authors><pubmed_authors>Xu JN</pubmed_authors><pubmed_authors>Ying XY</pubmed_authors><pubmed_authors>Li CR</pubmed_authors><pubmed_authors>Zhu FY</pubmed_authors><pubmed_authors>Zhang SD</pubmed_authors><pubmed_authors>Yang LL</pubmed_authors><pubmed_authors>Xie SY</pubmed_authors><pubmed_authors>Yao HJ</pubmed_authors><pubmed_authors>Yang ZX</pubmed_authors><pubmed_authors>Yue F</pubmed_authors><pubmed_authors>Wang Q</pubmed_authors><pubmed_authors>Wang RL</pubmed_authors><pubmed_authors>Cao Y</pubmed_authors><pubmed_authors>Wang LL</pubmed_authors><pubmed_authors>Cui CC</pubmed_authors><pubmed_authors>Yang YJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>BIN2 inhibition suppress ovarian cancer progression meanwhile protect ovarian function through downregulating HDAC1 and RPS6 phosphorylation respectively.</name><description/><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-07-15T04:11:22.662Z</modification><creation>2025-04-04T11:05:21.085Z</creation></dates><accession>S-EPMC11480968</accession><cross_references><pubmed>39412213</pubmed><doi>10.1002/ctm2.70051</doi></cross_references></HashMap>